Molecular Editing by Nitrogen Insertion

NINSERT aims to develop selective nitrogen insertion methods for late-stage skeletal editing in heterocycles, enhancing drug synthesis and tailoring compound profiles for pharmaceutical research.

Subsidie
€ 1.462.500
2025

Projectdetails

Introduction

NINSERT constitutes a program to embark on selective and mild nitrogen insertions, both within and beyond carbonyl chemistry. Reagent development, catalyst design, and synergistic effects will be evaluated to provide a platform for late-stage skeletal editing, an area that has been recently brought to the forefront of organic chemistry.

Focus on Heterocycles

With a primary emphasis on heterocyclic motifs, commonly encountered in natural products and drug candidates, NINSERT offers a powerful tool to streamline future syntheses of nitrogen-containing compounds. Notably, approximately 59% of all small-molecule drugs feature nitrogen heterocycles, underscoring the profound impact this program will have on pharmaceutical research.

Tailoring Compound Profiles

Adjusting physicochemical properties by late-stage nitrogen insertion will enable medicinal chemists to tailor the overall compound profile on its way to candidate nomination and ultimately clinical studies.

Asymmetric Methods

Furthermore, asymmetric methods, as elucidated in this proposal, will give rise to molecular complexity within the 3D chemical space. Guided by the principles of strain-release and molecular recognition, we will utilize our expertise on asymmetric ring expansion and atom insertion reactions to deliver highly selective methods applicable to both academic and industrial research.

Historical Context

Despite the pioneering work of Beckmann and Schmidt over a century ago, nitrogen insertions have remained significantly constrained over the years, largely due to their substrate limitations, harsh reaction conditions, and unselective outcomes.

Conclusion

The progression to selective and widely applicable nitrogen insertions has been long overdue and marks a major driving force behind the development of NINSERT.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.462.500
Totale projectbegroting€ 1.462.500

Tijdlijn

Startdatum1-3-2025
Einddatum28-2-2030
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • JOHANNES GUTENBERG-UNIVERSITAT MAINZpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Reconstructing enzymes for novel nitrogen-nitrogen bond forming chemistry

ReCNNSTRCT aims to develop a versatile enzymatic toolbox for synthesizing N-N bonds, enhancing green chemistry and drug discovery through innovative biocatalytic methods.

€ 1.500.000
ERC Advanced...

Harnessing the Catalytic Potential of Nitrogenases

GOFIXIT aims to develop a recombinant nitrogenase enzyme system in food crops to enhance biological nitrogen fixation, reducing reliance on harmful industrial fertilizers.

€ 2.963.906
ERC Starting...

Converting N2 directly into amines through multimetallic catalysis

The project aims to develop innovative multimetallic catalysts for the direct and efficient conversion of dinitrogen (N2) into amines, promoting sustainable amine synthesis.

€ 1.575.000
ERC Advanced...

Energy Transfer Catalysis: A Highway to Molecular Complexity

HighEnT aims to innovate synthetic methodologies using visible light-mediated EnT catalysis to create complex organic molecules for pharmacological applications, enhancing chemical space and reaction design.

€ 2.499.250
ERC Proof of...

Thermodynamically Robust Transfer Reagents for Molecular Editing

The project aims to develop safer, robust sulfur-based reagents for transferring functional groups in organic synthesis, enhancing applications in drug discovery and crop science while facilitating commercialization.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Inhibitor-Mediated Programming of Glycoforms

The project aims to revolutionize glycan manipulation using Inhibitor-Mediated Programming of Glycoforms (IMProGlyco) to create precision-engineered therapeutic proteins and enhance cellular functions.

€ 2.998.878
EIC Pathfinder

A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system

The NANO-ENGINE project aims to develop an affordable, scalable, and safe DNA-based in vivo cell programming technology using Targeted Nanoparticles to enhance accessibility of cell therapies for various diseases.

€ 2.988.377